ADELPHI, Maryland (Reuters) - Drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch should be simplified to better explain the risk of blood clots. Advisers ...

WASHINGTON (Reuters) - A U.S. advocacy group is urging the Food and Drug Administration to pull Johnson & Johnson's birth control patch from the market after studies found an increased risk of ...

It’s should be common knowledge that the Johnson & Johnson (J&J) Ortho-Evra birth-control patch has more risks than the birth control pill (it’s on the label) — because it exposes women to higher ...

The Ortho Evra patch, one of the most popular birth control methods distributed at ASU, may put women at greater risk for blood clots, warned the Food and Drug Administration last week. The FDA ...

FORT WORTH, Texas, Nov. 28 /PRNewswire/ -- The maker of the Evra* birth control patch sold in Canada is warning women there that they are at "particularly high risk" of developing blood clots if they ...

Johnson & Johnson misled doctors and regulators for years by altering and withholding medical data about the health risks of its Ortho Evra birth-control patch, lawyers for women suing the company ...

The patch supplies norelgestromin and ethinyl estradiol to the bloodstream through the skin. Has any evidence of genital swelling been documented with the use of the patch when placed inappropriately?